Concepedia

Pembrolizumab (pembro) + chemotherapy (chemo) in metastatic squamous NSCLC: Final analysis and progression after the next line of therapy (PFS2) in KEYNOTE-407

L. Paz-Ares, David Vicente, Ali Tafreshi, Andrew Robinson, Héctor Soto Parrà, Julien Mazières, Bárbara Hermes, Balazs Medgyasszay, Jerónimo Rodríguez Cid, Isamu Okamoto,

Annals of Oncology · 2019 · 18 citations · 0 references

DOI

Concepts